MEMBER'S LOGINX

Remember Username
Keep me signed in

(Please do not use this option on a public machine)

Print
Text -Size
RSS
FaceBook
Twitter
LinkedIn
WhatsApp

Home
Todays Market
Indian Stock Market Updates March 13, 2020

Markets will remain closed on 14^th April, 2021 on account of Dr. Baba Saheb Ambedkar Jayanti.

SUN PHARMA Surges by 7%; BSE HEALTHCARE Index Up 0.4%
Fri, 13 Mar 10:51 AM

SUN PHARMA share price has zoomed 7% and is presently trading at Rs 390.

Meanwhile, the BSE HEALTHCARE Index is at 12,298 (up 0.4%).

Among the top Gainers in the BSE HEALTHCARE Index today are SUN PHARMA (up 7.4%) and AUROBINDO PHARMA (up 10.0%).

NARAYANA HRUDAYALAYA LTD and SUN PHARMA ADV. RES. (down 0.4%) are among the top losers today.

Over the last one year, SUN PHARMA has moved down from Rs 470 to Rs 390, registering a loss of Rs 80 (down 19.0%).

On the other hand, the BSE HEALTHCARE has moved down from 14,333 to 12,298, loss of 2,035 points (down 14.2%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were ABBOTT INDIA (up 90.4%), DR. LAL PATHLABS LTD (up 48.9%) and J.B.CHEMICALS (up 48.8%).

Revealed: 3 Stocks for Potentially Massive Gains

What About the Benchmark Indices?

The BSE Sensex is at 32,392 (down 1.3%).

The top gainers among the BSE Sensex stocks today are SUN PHARMA (up 7.4%), HDFC (up 1.7%) and BAJAJ FINANCE (up 0.7%). Other gainers include BHARTI AIRTEL (up 0.4%) and ICICI BANK (up 0.3%). The most traded stocks in the BSE Sensex are HDFC BANK and ICICI BANK.

In the meantime, NSE Nifty is at 9,520 (down 1.0%). SUN PHARMA (up 7.7%) and YES BANK (up 6.4%) are among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved down from 37,536 to 32,392, registering a loss of 5,144 points (down 13.8%).

SUN PHARMA Financial Update...

SUN PHARMA net profit down at Rs 10 billion for the quarter ended December 2019, compared to a loss of Rs 15 billion a year ago. Net Sales rose 5.4% to Rs 81.5 billion during the period as against Rs 77.4 billion in October-December 2018.

For the year ended March 2019, SUN PHARMA reported 25.7% increase in net profit to Rs 44.2 billion compared to net profit of Rs 35.2 billion during FY18.

Revenue of the company grew 9.7% to Rs 291 billion during FY19.

The current Price to earnings ratio of SUN PHARMA, based on rolling 12 month earnings, stands at 20.7x.